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Abstract
For purpose to study specificity in the growth inhibition effect of sensitized lymph-node cells
on target cells, the regional lymph-node cells obtained from the truly isologous mouse previously
inoculated with A strain cells (derived from C3H mouse mammary cancer) were cultured with
A cells in various ways, and obtained the following results. 1. Those regional lymph-node cells
from the isologous mice transplanted with the skin of C3H mouse or MC-induced sarcoma do
not inhibit the growth of A cells in tissue culture. 2. The regional lymph-node cells from the
mice positive to tuberculin test also do not inhibit the growth of A cells in tissue culture. 3. The
regional axillary lymph-node cells (C3H anti-A strain cells) inhibit the proliferation of M cells
from Cb mouse mammasy cancer and JTC-ll cells from Ehrlich ascites tumor as well as A cells.
However, these axillary lymphnode cells do not inhibit the growth of AH-66F cells from rat DAB
hepatoma, Hela-S3 cells from human uterine cancer and L cells from subcutaneous connective
tissue of C3H mouse. From these results it is assumed that the sensitized regional lymph- node
cells act specifically on cancer antigen.
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In the previous paper it was reported1 that in the transplantation of A strain
cells (derived from C3H mouse mammary cancer) to isologous mice regional
lymph-node cells from the host showed at a certain early stage after the trans-
plantation an inhibitory effect on the proliferation of A strain cells in tissue
culture, and it was deduced that this phenomenon was attributable to the sen-
sitization of the regional lymph-node cells by cancer antigen. For the clarification
of the problem whether such an interaction between cancer cells and lymph-node
cells in vitro is a reflection of immunological reactions or not, it is necessary
to determine whether there is specificity in such reaction. For this purpose a
series of experiments was conducted to see whether regional lymph-node cells
from the isologous mice transplanted with skin graft of C3H mouse or methyl-
cholanthrene-induced sarcoma or lymph-node cells from the mice positive to
tuberculin test, will inhibit the proliferation of A strain cells. Concurrently, a
study was made to see whether or not the regional lymph-node cells from the
C3H mice transplanted with A strain cells would inhibit the growth of homolo-gous and heterologous tissue culture cells. As the result it was found that in the
interaction between antigenic cells and regional lymph-node cells in vitro thereis a considerable specificity, and this is probably due to the specific action of
regional lymph-node cells on cancer antigen. This report describes principal
findings of such a study.
MATERIALS AND METHODS
Animals: Inbred C3H female (H-2k) mice of age range, 6.......,8 weeks old, weredivided into three large groups.
Antigens for sensitization: Skin graft of full thickness from C3H mouse,
methylcholanthrene-induced sarcoma in C3H mouse, and A strain cells derived
from C3H mouse mammary cancer served as antigen. To obtain tuberculin-
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positive mice BCG in Freund's adjuvant was used. For the control groups
complete and incomplete Freund's adjuvants were used.
Sensitization of mice and preparation of lymph-node cell suspensions:
First group is divided into two subgroups, and with one subgroup the skin graft
1. 2cm in diameter is transplanted to isologous C3H mice on the back between
the scapulas by the method of BILLINGHAM and MEDAW AR2, and axillary lymph
nodes are taken out 9 days after the transplantation. To the other subgroup
three slices (lmmS) of methylcholanthrene-induced sarcoma are transplanted to
isologous under the skin on the back between the scapulas and regional lymph
nodes are removed on about 14 days afterwards when the tumor has grown to
the size about 1 cm in diameter.
The regional lymph nodes from respective subgroup are cut into small pieces
with ophthalmic scissors, passed through SO-mesh filter, washed three times by
centrifugation at 2, 000 rpm for 5 min each in cold Hank's solution, and after
removing serum, the cells are suspended in the 50 % bovine serum plus YLE
medium and this serves as the lymph-node cells suspensions. These suspensions
are named as iso-L and MC-L respectively.
The second group is divided into three subgroups, and to one group 1 ml of
complete Freund's adjuvant mixed with 0.5 mg BCG is injected subcutaneously
on the back, once a week later 0.5 ml BCG is injected into the tail vein, two
weeks afterward, confirming the animals to be positive to the tuberculin test in
the skin, axillary lymph nodes are taken out. To the second and third subgroups
1 ml each of complete and incomplete Freund's adjuvant is injected subcutaneously,
and axillary lynph nodes are taken out three weeks later. Cell suspensions are
prepared in the same manner as in the first group, and each of these suspensions
is designated B-L, coL and i-L respectively.
To the third group 5 X 106 A strain culture cells derived from C3H mouse
mammary cancer are transplanted snbcutaneously on the back, and on the tenth
day after the transplantation regional lymph nodes are taken out. Cell suspension
is prepared in the same way as in the first group and it is designated A-L.
With every group axillary lymph nodes of untreated normalC3H mice serve
as control, and the lymph-node cell suspension prepared with them is n-L.
Tissue culture cells: 1) A strain culture cells derived from C3H female
mouse (H-2k) mammary cancer; 2) L cells, derived from subcutaneous connec-
tive tissue of C3H mouse; 3) M strain culture cells, mammary cancer cells
derived from Cb femals mouse tH-2d); 4) lTC-II strain cells, derived from
Ehrlich ascites tumor; 5) AH-66F strain cells derived from rat DAB hepa-
toma; and 6) HeLa-Ss cells derived from human uterine cancer. Of these six
cell strains, A-cells, M cells and HeLa·S~ cells are at first treated with 0.25 %
trypsin GKN solution and A cells and M cells are suspended in 50 % bovine
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serum +YLE medium. JTC-ll cells and AH-66F cells are detached gently from
the waH of test tube with a rubber cleaner and by adding 2096 bovine serum
+YLE medium, the cell suspension is prepared. L cells were cultured by a
similar method in 10% bovine serum +YLE medium.
Culture of lymph-node cells and tissue culture cells:
Experiment 1: Iso-L and MC-L lymph-node cell suspensions of the first
group are mixed with A-strain cells and cultured in the medium optimal to A
cells at 37°C.
Experiment 2: B-L, coL, i-L lymph-node cell suspensions of the second
group are each mixed with A-cells and cultured in the identical medium in the
sa~e way.
Experiment 3: In the third group A-L lymph-node cell suspension is mixed
with A cells, L cells, M cells, JTC-11 cells, AH· 66F and HeLa-Ss cells and
these respective mixed cells are cultured in the media optimal to each culture
cell.
In every tissue culture n-L suspension is used as the control and are cultured
with each of tissue culture cells as in the experimental groups. For one series
of tissue culture, 16 X 100/ml of lymph-node cells and 4 X 104/ml of tissue culture
cells are mixed and 100u/ml of penicillin are added making the final volume to
10 ml. 1. 5 ml of this mixture in each series are pipetted to six short test tubes
and cultured.
The culture method is the replicate cell culture of EVANS et al. s and the
culture is conducted at 37 ° C. In Experiment 1 the cell counts are taken of 3 test
tubes each at culture time 29 and 52 hours; in Experiments 2 and 3 at the
culture time 24 and 48 hours. In the cell counting processes, the medium is
decanted, crystal violet solution is added, and after incubating for 30 minutes
at 37°C, the cells attached to the t!lbe wall are gently detatched by a rubber
cleaner, and a uniform cell suspension is prepared by a gentle stirring. A
droplet of the cell suspension is placed on BUrker-TUrk hemocytometer and the
cell counts are taken more than six times for each test tube and the average of
three test tubes is taken as the increase in the number of the target cells.
RESULTS
Experiment 1 : It was found that both the regional lymph-node cells
(iso-L) obtained from C3H female mouse after isotransplantation of the skin and
those cells (MC-L) obtained from the C3H mouse after the isotransplantation of
MC-induced sarcoma did not inhibit the proliferation of A cells (Fig. 1).
Taking the number of A cells at the time of addition of n-L (control) as 100
per cent, at the culture hour 52, iso-L cells seem to have inhibited the prolifera-
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I A_LIE~~1'(0.'01II MC-L 1'/0.1
III iSO-L. P )0.1
50 100%
29 hr later
50
52 hr later
Fig. 1 Percentage of inhibitory effect of A-L, MC-L and iso-L cells
on A strain cells
Note: 0 This column denotes the percentage of inhibition.
I denotes A-L +A strain cells, II denotes MC-L +A strain
cells, and III denotes iso-L + A strain cells.
Percentage of increase in the number of culture cells is expressed as
the number of culture cells at the addition of regional lymph-node cells X 100
the number of culture cells at the addition of normal lymph-node cells .
For the method, see text.
tion of A cells about 87 per cent but on comparing 65 per cent inhibition shown
by A-L, there is hardly any significant difference observable.
Experiment 2: Everyone of the lymph-node cells (B-L), from the mice
positive to the tuberculin test and coL, and i-L, do not inhibit the growth of A
cells (Fig. 2).
:~:'I9i;;;ii=L:::::,I-LI~ [;')0,1
50 lOO;:
24 hr later
IJ_LI~~LT')O'lc-L . 1')0.1
j-L 1')0.1
50 l()Oj~
48 hr later
Fig. 2 Percentage of inhibitory effect of B-L, coL, and i·L cells on A strain cells
Note: 0 This column denotes the percentage of inhibition.
B-L : The lymph-node cells from the C3H mouse positive to the
tuberculin test.
coL The lymph-node cells from the C3H mouse 3 weeks after
the injection of complete adjuvant.
i-L The lymph-node cells from the C3H mouse 3 weeks after
the injection of incomplete adjuvant.
For the method, see text.
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Experiment 3: The regional lymph-node cells (A-L) obtained 10 days
after the isotransplantation of A cells show the inhibitory effect on the prolifera-
tion of A cells as high as 40......... 60 percent, and on those homologous cells such as
M cells and JTC·ll cells likewise by 30.........40 per cent. On the other hand,
these regional lymph-node cells show hardly any inhibitory effect on the growth
of L cells, fibroblasts derived from C3H mouse and heterologous cells such as
AH-66F and HeLa-Ss cells (Fig. 3).
( A cells P(O.Ol
II L cells P)O.l
111 M cells P<0.02
IV JTC-Il P(0.02
V AII-66l'
P)O.l
VI IleLa-S) P)O.l
50 100%
24 hr later
I A cells P<O.Ol
II L Cf'lls P)O.l
JlI M cell, P(0.02
IV JTC-l1 P<O.Ol
V All-66l' P )0.05
VI lie La-53 P)O.l
50 100%
48 hr later
Fig. 3 Percentage of inhibition on the proliferation of I-VI culture cells
by regional lymph-node cells obtained 10 days after the isotrans-
plantation of A strain cells
Note: D This column denotes the percentage of inhibition.
For the method, see text.
DISCUSSION
From the fact that the regional lymph-node cells (A-L) from isologous C3H
mouse transplanted with A cells derived from C3H mouse mammary cancer
apparently inhibit the proliferation of A cells in tissue culture, there arises a
question what factor or factors are responsible for this inhibitory effect. The
first reason for it seems to be that there is a difference in histocompatibility gene
and hence it is possible for C3H mouse to recognize A cells as not-self. Looking
at the results of Experiment 1 in both isografting of skin in full thickness and
the isotransplantation of MC-induced sarsoma to C3H mice, the regional lymph-
node cells from these mice do not inhibit the growth of A cells in tissue culture,
and further, in the mutual exchange of skin graft between C3H mice the skin
graft survives permanently on each anima14 and this means that A cells have the
same histocompatibility as C3H mouse. Consequently, the inhibitory effect
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of A-L cells on A cell seems not to be caused by the difference in histocom-
patibility gene. Another question is whether or not those lymph-node cells
obtained from the animal in the state of delayed hypersensitivity would show
specifically anti-tumor activity in vitro. There are reports6 that in vivo the
animal treated with BeG shows anti-tumor activity against transplanted cancer.
As can be seen from the results in Experiment 2, those lymph-node cells (B-L)
from the mouse proven positive to the tuberculin test as well as CoL and i-L cells
all do not inhibit the proliferation of A cells in tissue culture. Therefore, the
second question would not support anti-tumor activity of A-L cells. Supposing
the first and second questions do not stand for reasoning, then there comes
another problem that A-L cells might induce the action of specific antigen (lack-
ing in C3H mouse) of A cells and cause anti-tumor activity. As observed in
Experiment 3, A-L cells do not at all inhibit the proliferation of heterologous
cells like AH-66F and HeLa-Ss cells, and also isologous L cells, but they do
inhibit A cells as well as homologous JTC-II and M cells. This means that in
the interaction in vitro between A-L and A cells there seems to be at least
species specificity. Furthermore, considering that everyone of A cell, lTC-II
cell and M cell is the mammary cancer cell derived from different strains of mouse
and that isologous MC-L cell has no effect on A cell, it is assumed that A-L cells
act on a specific antigen common in mouse mammary cancer. In Experiment 3,
the fact A-L inhibits most markedly A cells suggests that A-L, aside from the
antigen common in mammary cancer, acts also on specific antigen of A cell.
In other words, A-L cells seem to be sensitized specifically by A cells.
BRONDZ6 conducted transplantation of Sa-I (benzpyrene-induced mouse spindle
cell sarcoma) and MX 5 (methylcholanthrene-induced sarcoma) to coisogenic
pair of mice that differ only in H-2 locus, and to coisogenic pair of mice that
differ in weak antigen other than H-2 locus either subcutaneously or intraperito-
neally and conducted the mixed tissue culture of lymphoid cells from these
animals and cancer cells, and found that only in the case where the donor cell
and the host cell differed in H-2 antigen, the donor cell is destroyed by the
lymphoid cells.
ROSENAU7 likewise have studied the effect of the sensitized lymphoid cells
from BALBI c mice inoculated with L cells, spleen cells of C3H mice or CIl7BL
mice on various cell lines in vitro. .As the result cell lines derived from the same
mouse strain as the cells used for sensitization are lysed by the sensitized lymphoid
cells but cell lines derived from other mouse strains or heterologous cells in gene-
ral are not destroyed. It means that lysis of donor cells occurs in the interaction
between the cells having different H-2 antigen.
TAYLORs states that the spleen cells from mouse or guinea pig sensitized with
L cells show a marked cytolytic effect on L cells as well as on fibroblasts of the
6
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sensitized guinea pig, and KOPROWSKI9 reports that the lymph-node cells of the
rat sensitized with guinea-pig spinal cord specifically destroy glial cells from the
brain tissue of newborn puppy but do not damage fibroblasts, meaning that each
case demonstrates organ specificity.
Judging from the findings of the in vitro experiments so far mentioned and
from the result of Klein's experimenfo. l1 showing that the resistance against
methylcholanthrene-induced sarcoma in the authochthonous mice is located in
the lymph-node cells of host, A-L cells seem to act specifically on cancer antigen
in vitro.
SUMMARY
For purpose to study specificity in the growth inhibition effect of sensitized
lymph-node cells on target cells, the regional lymph-node cells obtained from the
truly isologous mouse previously inoculated with A strain cells (derived from
C3H mouse mammary cancer) were cultured with A cells in various ways, and
obtained the following results.
1. Those regional lymph-node cells from the isologous mice transplanted
with the skin of C3H mouse or MC-induced sarcoma do not inhibit the growth
of A cells in tissue culture.
2. The regional lymph-node cells from the mice positive to tuberculin test
also do not inhibit the growth of A cells in tissue culture.
3. The regional axillary lymph-node cells (C3H anti-A strain cells) inhibit
the proliferation of M cells from Cb mouse mammasy cancer and JTC-ll cells
from Ehrlich ascites tumor as well as A cells. However, these axillary lymph-
node cells do not inhibit the growth of AH-66F cells from rat DAB hepatoma,
Hela-Ss cells from human uterine cancer and L cells from subcutaneous connec-
tive tissue of C3H mouse.
From these results it is assumed that the sensitized regional lymph-node
cells act specifically on cancer antigen.
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